The Biotech Index is up 205% since Jan 2009, after FIVE CONSECUTIVE annual gains of 15%, 14%, 13%, 15%, then 69% last year, as well as 12% so far in 2014

Livewire
The Biotech Index is up 205% since Jan 2009, after FIVE CONSECUTIVE annual gains of 15%, 14%, 13%, 15%, then 69% last year, as well as 12% so far in 2014. The chart is spectacular: (VIEW LINK), and surely has only so much longer to run in this perpendicular ascent? Life science analysts make a good case for why it still has legs, but caution still seems wise. Barrons wrote: While the fundamentals are better than the S&P500, we anticipate that generalists will move away from biotech to other sectors when the macro environment improves. Until then, large-cap biotech will continue to post solid gains, but even large cap valuations are getting stretched. The upshot: We expect further consolidation and volatility but looks like the sector has another leg up, Werber says. [Be] cognizant that valuation is rich already so watch for signs of continued sell off. (VIEW LINK)
Welcome to Livewire, Australia’s most trusted source of investment insights and analysis.
To continue reading this wire and get unlimited access to Livewire, join for free now and become a more informed and confident investor.

The Livewire Equities feed brings you a range of insights that relate to Australian equities
Expertise
No areas of expertise

The Livewire Equities feed brings you a range of insights that relate to Australian equities
Expertise
No areas of expertise